Straits Times Index
3,187.66 +32.97 (+1.05%) S&P 500
5,011.12 -11.09 (-0.22%) Dow
37,775.38 +22.07 (+0.06%) Nasdaq
15,601.50 -81.87 (-0.52%) Bitcoin USD
63,537.96 +2,221.32 (+3.62%) CMC Crypto 200
885.54 0.00 (0.00%)
R1 RCM Inc. (RCM)
After hours:
| Previous close | 12.15 |
| Open | 12.12 |
| Bid | 12.01 x 700 |
| Ask | 12.04 x 700 |
| Day's range | 12.02 - 12.20 |
| 52-week range | 8.87 - 18.70 |
| Volume | |
| Avg. volume | 3,690,772 |
| Market cap | 5.057B |
| Beta (5Y monthly) | 0.78 |
| PE ratio (TTM) | 1,202.00 |
| EPS (TTM) | 0.01 |
| Earnings date | 14 Feb 2024 - 19 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 16.93 |
GlobeNewswireR1 RCM to Release First Quarter 2024 Results on May 8, 2024
MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the confere
- GlobeNewswire
R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report
Report highlights R1’s commitment to corporate responsibility and sustainability across the company’s global footprintMURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report. The report details the company’s commitment to improving access to healthcare, bringing
- GlobeNewswire
R1 RCM Forms Special Committee to Evaluate Strategic Alternatives
MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the
